Biotechnology Law with Vern Norviel

A Fireside Chat & Q&A

Now Streaming On-Demand

Summary

What impact do legal and regulatory systems have on biotechnology companies, academic research, products, and intellectual property (IP)? Join this fireside chat featuring Vern Norviel. Vern will draw on his decades of experience formulating successful IP programs for life science companies to discuss developing effective IP strategies and navigating the legal, corporate, ethical, and regulatory challenges in the biotechnology and pharmaceutical industries.


Plus, learn more about Vern's Biotechnology Law course, which is available online and is part of the Drug Development: From Discovery to Commercialization Graduate Certificate program. During this fireside chat, there will also be an opportunity for the audience to ask questions.



  • The most common blindspots managers struggle with while leading remote teams
  • The most common blindspots managers struggle with while leading remote teams
  • The most common blindspots managers struggle with while leading remote teams
  • Item 4
Presented By
Biotechnology Law Graduate Course
Questions?

Register to Attend

Share this webinar
CTA BTN

Speaker

Officia Deserunt

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Officia Deserunt

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Vern Norviel

Vern Norviel is an Affiliated Scholar at the Stanford Center for Innovation in Global Health and a partner and senior practitioner in innovation counseling at the law firm Wilson Sonsini Goodrich & Rosati. With three decades of experience in developing successful strategies for life science companies and assisting them in creating intellectual property programs, Vern represents a diverse array of companies and venture capital firms. His areas of expertise include therapeutics, diagnostics, nanotechnology, genomics, proteomics, and personalized medicine.

Officia Deserunt

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Officia Deserunt

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Officia Deserunt

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Register Now